Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 6, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Anaplastic large cell neuroblastoma.

Carlos R Abramowsky1, Howard M Katzenstein, Carlos S Alvarado

  • 1Department of Pathology and Pediatrics, Children's Healthcare of Atlanta at Egleston and Emory University School of Medicine, Atlanta, GA, USA. cabramo@emory.edu

Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
|April 10, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric Personalized Deep Learning Models for Segmentation of Hepatoblastoma at CT and MRI.

Radiology. Imaging cancer·2026
Same author

Implementation of Comprehensive Surgical Guidelines for Hepatoblastoma: Analysis of the Children's Oncology Group AHEP0731 Phase III Trial.

Annals of surgery·2025
Same author

Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study.

Clinical genitourinary cancer·2024
Same author

Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531.

Pediatric blood & cancer·2024
Same author

The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution.

EClinicalMedicine·2024
Same author

Evaluating Oncologists' Practice Patterns and Decision-Making in Locally Advanced or Metastatic Urothelial Carcinoma: The US Physician PARADIGM Study.

The oncologist·2023
Same journal

Rhabdomyomatous Mesenchymal Hamartoma With Prominent Folliculosebaceous Hyperplasia in an Infant's Philtrum: A Case Report.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2026
Same journal

Heterotopic Salivary Gland in the Rectum Associated with Lumbosacral Lipomeningocele: A Dual Developmental Anomaly.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2026
Same journal

Assessing Normal Histologic Patterns in Perinatal Tissue: A Practical Guide.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2026
Same journal

Perinatal Autopsy Guidance for the General Pathologist.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2026
Same journal

The Placenta: Identifying Normal.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2026
Same journal

Ancillary and Advanced Techniques for the Postmortem Examination.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2026
See all related articles

Anaplastic large cell neuroblastomas (ALCNB) are challenging to diagnose but show promising treatment outcomes. These tumors, despite unique markers like Fli-1 positivity, are confirmed as neuroblastomas through N-MYC amplification and maturation post-therapy.

Area of Science:

  • Pediatric Oncology
  • Cancer Biology
  • Pathology

Background:

  • Anaplastic large cell neuroblastomas (ALCNB) present diagnostic challenges due to pleomorphic and anaplastic features.
  • ALCNB are a subset of undifferentiated neuroblastomas requiring careful characterization.

Purpose of the Study:

  • To review clinical, biologic, and pathologic characteristics of ALCNB patients.
  • To evaluate treatment outcomes for ALCNB.

Main Methods:

  • Retrospective review of 7 ALCNB patients diagnosed between 1998-2006.
  • Analysis of clinical presentation, N-MYC amplification, catecholamine levels, immunohistochemistry (NSE, synaptophysin, chromogranin, Fli-1, CD-99), and molecular testing (Ewing sarcoma transcripts).
  • Assessment of posttreatment biopsies and patient survival.

Related Experiment Videos

Last Updated: Jul 6, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Main Results:

  • All patients had high-risk, abdominal-pelvic or thoracic masses.
  • N-MYC amplification occurred in 3 cases; elevated catecholamines in 5/6.
  • Tumors showed pleomorphic morphology, positive NSE, synaptophysin, and Fli-1, but negative CD-99 and Ewing sarcoma transcripts.
  • Posttreatment biopsies revealed maturation in 5/7 cases.
  • Five of seven patients survived, with a median follow-up of 25 months.

Conclusions:

  • ALCNB are characterized by undifferentiated morphology, NSE/synaptophysin positivity, Fli-1 positivity, and negative CD-99/EWS transcripts.
  • N-MYC amplification, catecholamine production, and posttherapy maturation support their neuroblastic origin.
  • Observed survival rates appear better than previously reported, warranting further investigation into optimal therapy and distinct biologic classification.